Sun Pharmaceutical Industries

Sun Pharma Q3 net profit zooms nearly four-fold to Rs 1,242 crore; firm's shares rise 2% on BSE

The company had posted a net profit of Rs 321.57 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE.

Sun Pharma arm gets relief from US court in patent infringement case

Massachusetts-based DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AGf from using its confidential and proprietary trade secret information, Sun Pharmaceutical Industries said

Sebi examines whistleblower complaint against Sun Pharma: All you need to know about issue plaguing drugmaker

In August 2017, Sun Pharmaceutical, Shanghvi and nine other entities settled an insider trading probe on payment of Rs 18 lakh towards settlement charges

Sun Pharma open to evaluate some past decisions; has not received any query so far from SEBI: Dilip Shanghvi

Dilip Shanghvi, founder and managing director of Sun Pharma said the company will work towards re-establishing credibility and corporate governance

Sun Pharma shares gain 4% after USFDA clears drug major; market cap rises by Rs 2,384 cr

Shares of Sun Pharmaceutical Industries on Wednesday gained nearly 4 percent after the company received establishment inspection report (EIR) from the US health regulator for its Halol facility in Gujarat

Sun Pharma receives EIR for its crucial Halol plant in Gujarat, US health regulator clears drug major

Sun Pharmaceutical Industries said it has received establishment inspection report (EIR) from US health regulator for its Halol facility in Gujarat

Sun Pharma shares drop over 3% on disappointing earnings in Jul-Sep quarter

Sun Pharma's consolidated total revenue from operations stood at Rs 6,650.34 crore

Sun Pharma forays into dermatology segment by launching sunscreen brand Suncros

The world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product

Lumbering economy, El Nino fear make HSBC downgrade Indian equities to 'underweight'

India remains one of the most over-owned market in Asia and the bank says the potential for more equity outflows has increased because foreign positions look stretched.

Sun Pharma gets RBI nod for transfer of Ranbaxy overseas investments

The two firms have received nod from the Competition Commission for sale of seven brands to Emcure Pharma to comply with the fair trade watchdog's conditional nod for their merger.